FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:61 July 4, 1996 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kimura, T. PubMed Citation

To the Editor: Kimura et al. reported (Feb. 29 issue)¹ that in patients treated with Palmaz–Schatz coronary-artery stents the rate of survival free of myocardial infarction, bypass surgery, and revascularization of the target lesion was 80.4 percent at one year. This rate is reported to be similar to results reported in the recent Stent Restenosis Study² and Benestent study³ and markedly higher than the one-year event-free rate of 66 percent given in the 1985–1986 Percutaneous Transluminal Coronary Angioplasty Registry of the National Heart, Lung, and Blood Institute (NHLBI).⁴ In fact, the definitions of events in the NHLBI registry report and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Guitart, J., Poiesz, B. J., Dube, D., Hutchison, R. (2000). HIV-1 and an HTLV-II-Associated Cutaneous T-Cell Lymphoma. NEJM 343: 303-304 [Full Text]